The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated Pediatric Influenza Patients during Two Influenza Seasons after the COVID-19 Pandemic: The Impact of Comorbidities on Hospitalization for Influenza in Children

Antiviral therapy such as oseltamivir has been recommended for hospitalized children with suspected and confirmed influenza for almost 20 years. The therapy is officially authorized for newborns two weeks of age or older, however, questions about its safety and effectiveness still surround it. Our g...

Full description

Bibliographic Details

Published in:	Viruses
Main Authors:	Gheorghiță Jugulete, Mihaela Cristina Olariu, Raluca Stanescu, Monica Luminita Luminos, Daniela Pacurar, Carmen Pavelescu, Mădălina-Maria Merișescu
Format:	Article
Language:	English
Published:	MDPI AG 2024-10-01
Subjects:	oseltamivir tolerability influenza children clinical effectiveness comorbidities
Online Access:	https://www.mdpi.com/1999-4915/16/10/1576